# A Comparative Study of New Medications for Psychosis in Adolescents

> **NCT00222495** · NA · COMPLETED · sponsor: **University of Minnesota** · enrollment: 30 (—)

## Conditions studied

- Psychotic Disorders
- Schizophrenia
- Schizophreniform Disorders
- Schizoaffective Disorders

## Interventions

- **DRUG:** quetiapine
- **DRUG:** olanzapine
- **DRUG:** risperidone

## Key facts

- **NCT ID:** NCT00222495
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 30 (—)
- **Last updated:** 2006-09-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222495, "A Comparative Study of New Medications for Psychosis in Adolescents". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00222495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*